Literature DB >> 29651511

[Follow-up care for gastrointestinal tumors].

M Ebert1.   

Abstract

The follow-up care of patients with gastrointestinal cancer is poorly defined. Prospective trials showing that regular follow-up care is advantageous are largely lacking. Follow-up is primarily based on symptom evaluation, as well as on an assessment of nutritional status and the need for psycho-oncological care. Whereas the evidence for regular endoscopic follow-up is well defined in early cancers, the role of follow-up care in advanced cancers is less well defined. This deficit is mainly due to the lack of therapeutic consequences in the case of recurrence. In such cases, cure is only rarely possible, and most studies have failed to demonstrate a survival benefit following standardized follow-up care of these patients. However, in view of the evolving treatment options in recurrent disease and the success of recurrent colorectal cancer treatment, it seems reasonable to define the current status of follow-up care for patients with gastrointestinal cancers.

Entities:  

Keywords:  Colorectal neoplasms; Esophageal neoplasms; Recurrence, gastrointestinal tumors; Risk assessment; Stomach neoplasms

Mesh:

Year:  2018        PMID: 29651511     DOI: 10.1007/s00108-018-0414-5

Source DB:  PubMed          Journal:  Internist (Berl)        ISSN: 0020-9554            Impact factor:   0.743


  19 in total

1.  Postoperative follow-up programs improve survival in curatively resected gastric and junctional cancer patients: a propensity score matched analysis.

Authors:  Leila Sisic; Moritz J Strowitzki; Susanne Blank; Henrik Nienhueser; Sara Dorr; Georg Martin Haag; Dirk Jäger; Katja Ott; Markus W Büchler; Alexis Ulrich; Thomas Schmidt
Journal:  Gastric Cancer       Date:  2017-07-24       Impact factor: 7.370

2.  Colorectal cancer follow-up: a reassessment of empirical evidence on effectiveness.

Authors:  J Kievit
Journal:  Eur J Surg Oncol       Date:  2000-06       Impact factor: 4.424

3. 

Authors:  Wolff Schmiegel; Barbara Buchberger; Markus Follmann; Ullrich Graeven; Volker Heinemann; Thomas Langer; Monika Nothacker; Rainer Porschen; Claus Rödel; Thomas Rösch; Wolfgang Schmitt; Simone Wesselmann; Christian Pox
Journal:  Z Gastroenterol       Date:  2017-12-06       Impact factor: 2.000

4.  Impact of co-morbidity on mortality after oesophageal cancer surgery.

Authors:  L Backemar; P Lagergren; A Johar; J Lagergren
Journal:  Br J Surg       Date:  2015-06-08       Impact factor: 6.939

Review 5.  Practice Guideline for the Surveillance of Patients After Curative Treatment of Colon and Rectal Cancer.

Authors:  Scott R Steele; George J Chang; Samantha Hendren; Marty Weiser; Jennifer Irani; W Donald Buie; Janice F Rafferty
Journal:  Dis Colon Rectum       Date:  2015-08       Impact factor: 4.585

6.  Yearly colonoscopy, liver CT, and chest radiography do not influence 5-year survival of colorectal cancer patients.

Authors:  D Schoemaker; R Black; L Giles; J Toouli
Journal:  Gastroenterology       Date:  1998-01       Impact factor: 22.682

Review 7.  Follow-up of patients with colorectal cancer: numbers needed to test and treat.

Authors:  J Kievit
Journal:  Eur J Cancer       Date:  2002-05       Impact factor: 9.162

8.  Cumulative incidence of metachronous colorectal cancer.

Authors:  R L Cali; R M Pitsch; A G Thorson; P Watson; P Tapia; G J Blatchford; M A Christensen
Journal:  Dis Colon Rectum       Date:  1993-04       Impact factor: 4.585

9.  The role of postoperative colonoscopic surveillance after radical surgery for colorectal cancer: a prospective, randomized clinical study.

Authors:  Ting Wang; Yi Cui; Wen-Sheng Huang; Yan-Hong Deng; Wei Gong; Chu-Jun Li; Jian-Ping Wang
Journal:  Gastrointest Endosc       Date:  2009-01-10       Impact factor: 9.427

10.  Consensus guidelines for diagnosis, treatment and follow-up of patients with pancreatic cancer in Spain.

Authors:  M Hidalgo; R Álvarez; J Gallego; C Guillén-Ponce; B Laquente; T Macarulla; A Muñoz; M Salgado; R Vera; J Adeva; I Alés; S Arévalo; J Blázquez; A Calsina; A Carmona; E de Madaria; R Díaz; L Díez; T Fernández; B G de Paredes; M E Gallardo; I González; O Hernando; P Jiménez; A López; C López; F López-Ríos; E Martín; J Martínez; A Martínez; J Montans; R Pazo; J C Plaza; I Peiró; J J Reina; A Sanjuanbenito; R Yaya; Alfredo Carrato
Journal:  Clin Transl Oncol       Date:  2016-12-19       Impact factor: 3.405

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.